Évelyne Newton is the Vice President of Business Development at Velocity Clinical Research. With over 20 years of experience in the healthcare and clinical research sector, she is responsible for leading key strategic partnerships and driving sales in Europe. Évelyne is also passionate about diversity, equity, inclusion, and belonging (DEIB), serving as the co-chair of the DEIB Council at Worldwide Clinical Trials (WCT). She has previously held positions at Fisher Clinical Services and Synexus, and her expertise is crucial for maximizing cross-selling opportunities and enhancing the customer experience for Velocity’s partners.
